BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study
John Munkhaugen(University of Oslo), Dan Atar, Morten Wang Fagerland(Oslo University Hospital), Jarle Jortveit(Sørlandet Hospital Arendal), Terje K. Steigen(University Hospital of North Norway), Kjell Vikenes(Haukeland University Hospital), Toril Dammen(Oslo University Hospital), Lars Køber(University of Copenhagen), Olaf Rødevand, Bjørn Bendz(Oslo University Hospital), Henrik Schirmer, Nils Tore Vethe(Oslo University Hospital), Rune Wiseth(Norwegian University of Science and Technology), Kjersti Helene Hernæs(Oslo University Hospital), Sigrun Halvorsen, Vidar Ruddox(Sykehuset i Vestfold), Alf Inge Larsen(Stavanger University Hospital), Thor Edvardsen(Oslo University Hospital), Eva Prescott(Frederiksberg Hospital), Jan Erik Otterstad(Sykehuset i Vestfold), Hans Erik Bøtker(Aarhus University), Terje Pedersen(Oslo University Hospital), Svend Eggert Jensen(Aalborg University Hospital)
Cited by 50
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest
|New England Journal of Medicine|2013|2.8k